Research

To fulfill our mission and discover treatments for PKD, the PKD Foundation is moving into drug repurposing. Drug repurposing is the process of developing new uses for an existing drug or  compound. This approach takes advantage of work that has been done for a different therapeutic use, therefore, cutting costs and time. Learn more.

 		 
 

 

An Introduction to PKD Research

The PKD Foundation leads the fight against PKD through vital research funding and patient education. Now clinical trials in cardiovascular health, Rapamycin, Somatostatin and Tolvaptan - as well as the PKD Foundation's new  Drug Repurposing Program, offer help and hope to the 12.5 million worldwide with PKD.

 

 		 
   
©2010, PKD Foundation  · The PKD Foundation is a 501 (c)(3), 509 (a)(1) public charity.